1. Home
  2. WVE vs RHI Comparison

WVE vs RHI Comparison

Compare WVE & RHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wave Life Sciences Ltd.

WVE

Wave Life Sciences Ltd.

N/A

Current Price

$13.35

Market Cap

2.4B

Sector

Health Care

ML Signal

N/A

Logo Robert Half Inc.

RHI

Robert Half Inc.

N/A

Current Price

$22.79

Market Cap

2.6B

ML Signal

N/A

Company Overview

Basic Information
Metric
WVE
RHI
Founded
2012
1948
Country
Singapore
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Professional Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
2.6B
IPO Year
2015
1994

Fundamental Metrics

Financial Performance
Metric
WVE
RHI
Price
$13.35
$22.79
Analyst Decision
Strong Buy
Hold
Analyst Count
15
6
Target Price
$31.47
$30.33
AVG Volume (30 Days)
2.2M
3.3M
Earning Date
01-01-0001
04-30-2026
Dividend Yield
N/A
10.20%
EPS Growth
N/A
N/A
EPS
N/A
1.33
Revenue
$3,704,000.00
$5,378,506,000.00
Revenue This Year
N/A
$1.57
Revenue Next Year
$119.93
$6.00
P/E Ratio
N/A
$17.39
Revenue Growth
149.43
N/A
52 Week Low
$5.28
$22.32
52 Week High
$21.73
$55.24

Technical Indicators

Market Signals
Indicator
WVE
RHI
Relative Strength Index (RSI) 47.54 35.19
Support Level $12.53 $22.32
Resistance Level $14.56 $28.35
Average True Range (ATR) 0.79 1.13
MACD 0.01 -0.06
Stochastic Oscillator 23.84 11.47

Price Performance

Historical Comparison
WVE
RHI

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

About RHI Robert Half Inc.

Robert Half Inc was founded in 1948, Robert Half provides temporary, permanent, and outcome-based staffing for both in-person and remote positions in the finance and accounting, technology, legal, marketing, and administrative fields. Its subsidiary consulting arm, Protiviti, specializes in technology, risk, auditing, and compliance matters. The firm generates its sales inside the U.S. and is one of the specialized firms in the fragmented U.S. staffing industry.

Share on Social Networks: